Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene highlights MS drug in diversification push
Celgene highlights MS drug in diversification push
Celgene highlights MS drug in diversification push
Submitted by
admin
on April 27, 2017 - 5:47pm
Source:
BioPharma Dive
News Tags:
Celgene
MS
multiple sclerosis
ozanimod
Headline:
Celgene highlights MS drug in diversification push
Do Not Allow Advertisers to Use My Personal information
